Evelo Biosciences Ownership 2024 | Who Owns Evelo Biosciences Now?


OverviewChart

Institutional Ownership

0.40%

Insider Ownership

0.14%

Retail Ownership

99.46%

Institutional Holders

1.00

Evelo Biosciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAYO CLINIC----22,577-100.00%-Dec 31, 2023

Evelo Biosciences's largest institutional shareholder is MAYO CLINIC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAYO CLINIC----22,577-100.00%-Dec 31, 2023

The largest Evelo Biosciences shareholder by % of total assets is MAYO CLINIC. The company owns 0.00 shares of Evelo Biosciences (EVLO), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAYO CLINIC----22,577-100.00%-Dec 31, 2023

As of Dec 31 2023, Evelo Biosciences's largest institutional buyer is MAYO CLINIC. The company purchased -22.58K stocks of EVLO, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAYO CLINIC----22,577-100.00%-Dec 31, 2023

As of Dec 31 2023, Evelo Biosciences's biggest institutional seller is MAYO CLINIC. The company sold -22.58K shares of EVLO, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MAYO CLINIC----22,577-100.00%-Dec 31, 2023

Evelo Biosciences's largest sold out institutional shareholder by shares sold is MAYO CLINIC, sold -22.58K shares, valued at -, as of undefined.

Evelo Biosciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY MT VERNON STREET TRUST0.14%3,908,340--Feb 29, 2024
BRIDGEWAY FUNDS INC0.04%105,300--Mar 28, 2024
VANGUARD VALLEY FORGE FUNDS0.04%22,014--Mar 31, 2024
FIDELITY CAPITAL TRUST0.03%379,400--Jan 31, 2024
Federated Hermes MDT Series0.03%70,217--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.02%466,900--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.02%1,098,999--Feb 29, 2024
FIDELITY COMMONWEALTH TRUST0.02%51,109--Feb 29, 2024
ETFis Series Trust I0.01%21,013--Jan 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%4,653--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%47,428--Mar 31, 2024
VANGUARD INDEX FUNDS0.01%3,062,966--Mar 31, 2024
Humankind Benefit Corp0.00%111--Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%887--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%492,530--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%54,959--Mar 31, 2024
FIDELITY ADVISOR SERIES I0.00%329,200--Feb 29, 2024
FIDELITY CAPITAL TRUST0.00%18,970--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.00%12,700--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%21,645--Mar 31, 2024
VICTORY PORTFOLIOS0.00%27,769--Mar 31, 2024
Calvert Variable Products, Inc.0.00%2,381--Mar 31, 2024
VANGUARD INDEX FUNDS0.00%348,664--Mar 31, 2024
AdvisorShares Trust0.00%3,207--Mar 28, 2024
SCHWAB CAPITAL TRUST0.00%31,345--Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%2,030--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%12,008--Mar 31, 2024
VANGUARD WORLD FUND0.00%85,629--Feb 29, 2024
SunAmerica Specialty Series0.00%165--Apr 30, 2021
GPS Funds I0.00%1,521--Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%51,357--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%2,640--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%13,449--Feb 29, 2024
Global X Funds0.00%8,579--Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%897--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%105,799--Feb 29, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,535--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%2,747--Mar 31, 2024
FIDELITY ADVISOR SERIES I0.00%16,460--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.00%635--Mar 31, 2024
RBB FUND, INC.0.00%6,908--Feb 29, 2024
HC CAPITAL TRUST0.00%2,314--Mar 31, 2024
RYDEX SERIES FUNDS0.00%289--Dec 31, 2023
NORTHERN FUNDS0.00%9,303--Mar 28, 2024
ProFunds0.00%649--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%212,429--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%103,556--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%1,052--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%161--Dec 31, 2023
VALIC Co I0.00%11,257--Feb 29, 2024
Guardian Variable Products Trust0.00%620--Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%4,051--Mar 31, 2024
Guggenheim Active Allocation Fund0.00%181--Feb 29, 2024
iSHARES TRUST0.00%482,382--Mar 31, 2024
PROSHARES TRUST0.00%7,320--Feb 29, 2024
FIDELITY HASTINGS STREET TRUST0.00%187,600--Mar 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%2,385--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%6,016--Jan 31, 2024
RYDEX VARIABLE TRUST0.00%29--Dec 31, 2023
VANGUARD WELLINGTON FUND0.00%9,937--Feb 29, 2024
PENN SERIES FUNDS INC0.00%700--Mar 28, 2024
TIAA-CREF FUNDS0.00%70,514--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%22,743--Mar 31, 2024
FLEXSHARES TRUST0.00%1,504--Jan 31, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%55,533--Dec 31, 2023
PACE SELECT ADVISORS TRUST0.00%4,786--Jan 31, 2024
Brighthouse Funds Trust II0.00%12,153--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%841--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,296--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%26,000--Mar 31, 2024
Blackstone Alternative Investment Funds0.00%600--Mar 31, 2023
ETF Series Solutions0.00%203--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%3,349--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%2,084--Jan 31, 2024
Dimensional ETF Trust0.00%2,455--Jan 31, 2024
PROSHARES TRUST0.00%1,201--Feb 29, 2024
EQ ADVISORS TRUST0.00%5,374--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%1,014--Jan 31, 2024
iSHARES TRUST0.00%64,989--Mar 31, 2024
PACIFIC SELECT FUND0.00%10,459--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%347--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%2,447--Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,392--Dec 31, 2023
GOLDMAN SACHS TRUST0.00%5,950--Mar 31, 2024
FIDELITY HASTINGS STREET TRUST0.00%9,380--Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%2,584--Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%310--Jan 31, 2024
AMERICAN CENTURY ETF TRUST0.00%99--Feb 29, 2024
PRINCIPAL FUNDS, INC.0.00%5,243--Feb 29, 2024
Bridge Builder Trust0.00%3,643--Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%3,622--Mar 31, 2024
PACIFIC SELECT FUND0.00%2,066--Mar 31, 2024
BLACKROCK FUNDS0.00%3,117--Mar 28, 2024
Advisors' Inner Circle Fund III0.00%35--Jan 31, 2024
John Hancock Funds II0.00%3,221--Feb 29, 2024
Meeder Funds0.00%1--Mar 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%3,300--Feb 29, 2024

Evelo Biosciences's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 3.91M shares, compromising 0.14% of its total assets.

Evelo Biosciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 231-
30 Jun, 231-97.30%
31 Mar, 2337-11.90%
31 Dec, 22427.69%
30 Sep, 2239-11.36%
30 Jun, 2244-34.33%
31 Mar, 2267-4.29%
31 Dec, 2170-11.39%
30 Sep, 217914.49%
30 Jun, 21699.52%
31 Mar, 216328.57%
31 Dec, 20494.26%
30 Sep, 20472.17%
30 Jun, 204615.00%
31 Mar, 2040-4.76%
31 Dec, 1942-
30 Sep, 194210.53%
30 Jun, 1938-7.32%
31 Mar, 19412.50%
31 Dec, 18408.11%
30 Sep, 1837-9.76%
30 Jun, 1841-

As of 30 Sep 23, 1 institutions are holding Evelo Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 2322,577-
30 Jun, 2322,577-99.97%
31 Mar, 2384,899,862-0.77%
31 Dec, 2285,562,8171.34%
30 Sep, 2284,434,3621.19%
30 Jun, 2283,441,45075.38%
31 Mar, 2247,578,027-0.46%
31 Dec, 2147,798,1821.55%
30 Sep, 2147,066,3910.20%
30 Jun, 2146,970,964-1.07%
31 Mar, 2147,477,48812.90%
31 Dec, 2042,051,0014.82%
30 Sep, 2040,116,453-1.60%
30 Jun, 2040,770,75142.47%
31 Mar, 2028,616,999-1.20%
31 Dec, 1928,965,7380.77%
30 Sep, 1928,743,7830.20%
30 Jun, 1928,686,7270.37%
31 Mar, 1928,582,3721.48%
31 Dec, 1828,165,8593.81%
30 Sep, 1827,131,9731.94%
30 Jun, 1826,616,560-

Evelo Biosciences (EVLO) has 22.58K shares outstanding as of 30 Sep 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 230.40%97450.98%
30 Jun, 230.02%0.00%
31 Mar, 2376.55%0.79%
31 Dec, 2298.16%1.61%
30 Sep, 2278.14%0.64%
30 Jun, 22110.20%1.40%
31 Mar, 2288.73%1.09%
31 Dec, 2190.34%1.16%
30 Sep, 2188.09%1.14%
30 Jun, 2187.99%1.03%
31 Mar, 2192.47%0.82%
31 Dec, 20106.51%1.41%
30 Sep, 2086.89%0.56%
30 Jun, 20124.93%1.59%
31 Mar, 2088.73%1.09%
31 Dec, 1990.43%1.12%
30 Sep, 1989.65%1.12%
30 Jun, 1989.53%1.12%
31 Mar, 1989.53%0.54%
31 Dec, 18128.78%1.76%
30 Sep, 1885.48%0.46%
30 Jun, 18135.61%-

As of 30 Sep 23, Evelo Biosciences is held by 0.40% institutional shareholders, representing a 97450.98% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 2312-50.00%
31 Dec, 222460.00%
30 Sep, 2215-11.76%
30 Jun, 2217-37.04%
31 Mar, 2227-27.03%
31 Dec, 2137-9.76%
30 Sep, 2141-
30 Jun, 2141-10.87%
31 Mar, 214639.39%
31 Dec, 203326.92%
30 Sep, 2026-16.13%
30 Jun, 2031106.67%
31 Mar, 2015-16.67%
31 Dec, 1918-10.00%
30 Sep, 1920-
30 Jun, 1920-9.09%
31 Mar, 1922-18.52%
31 Dec, 182728.57%
30 Sep, 1821-48.78%
30 Jun, 1841-

- institutional shareholders have increased their position in EVLO stock as of 30 Sep 23 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 23--100.00%
30 Jun, 231-90.00%
31 Mar, 231042.86%
31 Dec, 227-46.15%
30 Sep, 2213-35.00%
30 Jun, 2220-20.00%
31 Mar, 222578.57%
31 Dec, 2114-
30 Sep, 2114-12.50%
30 Jun, 211633.33%
31 Mar, 211250.00%
31 Dec, 208-27.27%
30 Sep, 201137.50%
30 Jun, 208-46.67%
31 Mar, 201525.00%
31 Dec, 191220.00%
30 Sep, 191025.00%
30 Jun, 198-27.27%
31 Mar, 191183.33%
31 Dec, 186-14.29%
30 Sep, 187-
30 Jun, 18--

- institutional shareholders have reduced their position in EVLO stock as of 30 Sep 23 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 231-22,577-0.40%97450.98%----100.00%
30 Jun, 231-97.30%22,577-99.97%0.02%0.00%--100.00%1-90.00%
31 Mar, 2337-11.90%84,899,862-0.77%76.55%0.79%12-50.00%1042.86%
31 Dec, 22427.69%85,562,8171.34%98.16%1.61%2460.00%7-46.15%
30 Sep, 2239-11.36%84,434,3621.19%78.14%0.64%15-11.76%13-35.00%
30 Jun, 2244-34.33%83,441,45075.38%110.20%1.40%17-37.04%20-20.00%
31 Mar, 2267-4.29%47,578,027-0.46%88.73%1.09%27-27.03%2578.57%
31 Dec, 2170-11.39%47,798,1821.55%90.34%1.16%37-9.76%14-
30 Sep, 217914.49%47,066,3910.20%88.09%1.14%41-14-12.50%
30 Jun, 21699.52%46,970,964-1.07%87.99%1.03%41-10.87%1633.33%
31 Mar, 216328.57%47,477,48812.90%92.47%0.82%4639.39%1250.00%
31 Dec, 20494.26%42,051,0014.82%106.51%1.41%3326.92%8-27.27%
30 Sep, 20472.17%40,116,453-1.60%86.89%0.56%26-16.13%1137.50%
30 Jun, 204615.00%40,770,75142.47%124.93%1.59%31106.67%8-46.67%
31 Mar, 2040-4.76%28,616,999-1.20%88.73%1.09%15-16.67%1525.00%
31 Dec, 1942-28,965,7380.77%90.43%1.12%18-10.00%1220.00%
30 Sep, 194210.53%28,743,7830.20%89.65%1.12%20-1025.00%
30 Jun, 1938-7.32%28,686,7270.37%89.53%1.12%20-9.09%8-27.27%
31 Mar, 19412.50%28,582,3721.48%89.53%0.54%22-18.52%1183.33%
31 Dec, 18408.11%28,165,8593.81%128.78%1.76%2728.57%6-14.29%
30 Sep, 1837-9.76%27,131,9731.94%85.48%0.46%21-48.78%7-
30 Jun, 1841-26,616,560-135.61%-41---

Evelo Biosciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 08, 2023Bodmer Markofficer CSO, President of R&DS-SaleSell3,163$0.33$1.04K25,732
Nov 08, 2023McHale Duncanofficer Chief Medical OfficerS-SaleSell3,103$0.33$1.02K16,984
Nov 08, 2023GILL SIMBAdirector, officer President & CEOS-SaleSell172$0.33$56.7617,758
Nov 08, 2023Thorell Marellaofficer Chief Financial OfficerS-SaleSell1,811$0.33$597.6322,259
Nov 03, 2023Bodmer Markofficer CSO, President of R&DS-SaleSell6,854$0.33$2.26K22,270
Nov 03, 2023McHale Duncanofficer Chief Medical OfficerS-SaleSell6,854$0.33$2.26K13,587

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 08, 2023Bodmer Markofficer CSO, President of R&DS-SaleSell3,163$0.33$1.04K25,732
Nov 08, 2023Bodmer Markofficer CSO, President of R&DM-ExemptSell6,625--6,625
Nov 08, 2023McHale Duncanofficer Chief Medical OfficerS-SaleSell3,103$0.33$1.02K16,984
Nov 08, 2023McHale Duncanofficer Chief Medical OfficerM-ExemptSell6,500--6,500
Nov 08, 2023GILL SIMBAdirector, officer President & CEOS-SaleSell172$0.33$56.7617,758
Nov 08, 2023GILL SIMBAdirector, officer President & CEOM-ExemptSell1,172--15,236
Nov 08, 2023Thorell Marellaofficer Chief Financial OfficerS-SaleSell1,811$0.33$597.6322,259
Nov 08, 2023Thorell Marellaofficer Chief Financial OfficerM-ExemptSell6,500--6,500
Nov 03, 2023Bodmer Markofficer CSO, President of R&DM-ExemptSell12,500--25,000
Nov 03, 2023Bodmer Markofficer CSO, President of R&DS-SaleSell6,854$0.33$2.26K22,270
Nov 03, 2023McHale Duncanofficer Chief Medical OfficerM-ExemptSell12,500--25,000
Nov 03, 2023McHale Duncanofficer Chief Medical OfficerS-SaleSell6,854$0.33$2.26K13,587
Nov 03, 2023Thorell Marellaofficer Chief Financial OfficerM-ExemptSell12,500--25,000

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 08, 2023Bodmer Markofficer CSO, President of R&DM-ExemptBuy6,625--28,895
Nov 08, 2023Bodmer Markofficer CSO, President of R&DS-SaleSell3,163$0.33$1.04K25,732
Nov 08, 2023Bodmer Markofficer CSO, President of R&DM-ExemptSell6,625--6,625
Nov 08, 2023McHale Duncanofficer Chief Medical OfficerM-ExemptBuy6,500--20,087
Nov 08, 2023McHale Duncanofficer Chief Medical OfficerS-SaleSell3,103$0.33$1.02K16,984
Nov 08, 2023McHale Duncanofficer Chief Medical OfficerM-ExemptSell6,500--6,500
Nov 08, 2023GILL SIMBAdirector, officer President & CEOM-ExemptBuy1,172--17,930
Nov 08, 2023GILL SIMBAdirector, officer President & CEOS-SaleSell172$0.33$56.7617,758
Nov 08, 2023GILL SIMBAdirector, officer President & CEOM-ExemptSell1,172--15,236
Nov 08, 2023Thorell Marellaofficer Chief Financial OfficerM-ExemptBuy6,500--24,070
Nov 08, 2023Thorell Marellaofficer Chief Financial OfficerS-SaleSell1,811$0.33$597.6322,259
Nov 08, 2023Thorell Marellaofficer Chief Financial OfficerM-ExemptSell6,500--6,500
Nov 03, 2023Bodmer Markofficer CSO, President of R&DM-ExemptBuy12,500--29,124
Nov 03, 2023Bodmer Markofficer CSO, President of R&DM-ExemptSell12,500--25,000
Nov 03, 2023Bodmer Markofficer CSO, President of R&DS-SaleSell6,854$0.33$2.26K22,270
Nov 03, 2023McHale Duncanofficer Chief Medical OfficerM-ExemptSell12,500--25,000
Nov 03, 2023McHale Duncanofficer Chief Medical OfficerM-ExemptBuy12,500--20,441
Nov 03, 2023McHale Duncanofficer Chief Medical OfficerS-SaleSell6,854$0.33$2.26K13,587
Nov 03, 2023Thorell Marellaofficer Chief Financial OfficerM-ExemptSell12,500--25,000
Nov 03, 2023Thorell Marellaofficer Chief Financial OfficerM-ExemptBuy12,500--21,569

The last insider sell of Evelo Biosciences's stock was made by Bodmer Mark on Nov 08 2023, selling 3,163 shares at $0.33 per share (valued at $1.04K).

Evelo Biosciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 202371450.00%
Q3 20231411127.27%
Q2 2023159166.67%
Q1 202372350.00%
Q3 20224--
Q2 2022134325.00%
Q1 2022154375.00%
Q4 202188100.00%
Q3 202133100.00%
Q2 20211411400.00%
Q1 202114--
Q4 202091900.00%
Q3 20207--
Q2 202010--
Q1 202063200.00%
Q4 20191--
Q3 20191--
Q2 20197--
Q1 20193--
Q4 20181--

7 total buy trades, and 14 total sell trades (buy/sell ratio of 0.50%) were made by Evelo Biosciences's insiders, as of Q4 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2023-7-
Q3 20233560.00%
Q2 2023-5-
Q1 2023-1-
Q3 2022---
Q2 20224--
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 20214--
Q4 202071700.00%
Q3 20206--
Q2 20204--
Q1 2020---
Q4 2019---
Q3 2019---
Q2 2019---
Q1 2019---
Q4 2018---

As of Q4 2023, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Evelo Biosciences's stocks.

Evelo Biosciences Peer Ownership


TickerCompany
NUVBNuvation Bio Inc.
MGTADianthus Therapeutics, Inc.
ENSCEnsysce Biosciences, Inc.
ABVCABVC BioPharma, Inc.
EWTXEdgewise Therapeutics, Inc.
ERASErasca, Inc.
CTMXCytomX Therapeutics, Inc.
GBIOGeneration Bio Co.
SRZNSurrozen, Inc.
APTXAptinyx Inc.
DRMADermata Therapeutics, Inc.
KRONKronos Bio, Inc.
CCCCC4 Therapeutics, Inc.
ASMBAssembly Biosciences, Inc.
TPSTTempest Therapeutics, Inc.
PCSAProcessa Pharmaceuticals, Inc.
WINTWindtree Therapeutics, Inc.
NLTXNeurogene Inc.
BXRXBaudax Bio, Inc.
ALRNAileron Therapeutics, Inc.
TILInstil Bio, Inc.

EVLO Ownership FAQ


Evelo Biosciences is owned by institutional shareholders (0.40%), insiders (0.14%), and public (99.46%). The largest institutional shareholder of Evelo Biosciences is MAYO CLINIC (0% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.14% of total shares).

Evelo Biosciences's major institutional shareholders are MAYO CLINIC. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 1 institutional shareholders of Evelo Biosciences.

MAYO CLINIC owns 0 shares of Evelo Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).